65638 Federal Register / Vol. 60, No. 244 / Wednesday, December 20, 1995 / Notices

from the CRADA as well as an option to

negotiate for exclusive royalty-bearing

licenses for NIST employee inventions

which arise from the CRADA.

The availability of the invention for

licensing was published in the Federal

Register, Vol. 53, No. 209 (October 28,

1988). A copy of the patent application

may be obtained from NIST at the

foregoing address.

Dated: December 14, 1995.

Samuel Kramer,

Associate Director.

[FR Doc. 95–30945 Filed 12–19–95; 8:45 am]

BILLING CODE 3510–13–M

Prospective Grant of Exclusive Patent

License; Pasadena Scientific

Industries

AGENCY: National Institute of Standards

and Technology, Commerce.

ACTION: Notice of prospective grant of

exclusive patent license.

SUMMARY: This is a notice in accordance

with 35 U.S.C. 209(c)(1) and 37 CFR

404.7(a)(1)(i) that the National Institute

of Standards and Technology (‘‘NIST’’),

U.S. Department of Commerce, is

contemplating the grant of a field of use

exclusive license in the United States to

practice the invention embodied in U.S.

Patent Number 5,389,523, titled,

‘‘Liposome Immunoanalysis By Flow

Injection Assay’’ to Pasadena Scientific

Industries, having a place of business in

Hanover, Maryland.

FOR FURTHER INFORMATION CONTACT:

Bruce E. Mattson, National Institute of

Standards and Technology, Technology

Development and Small Business

Program, Building 221, Room B–256,

Gaithersburg, MD 20899.

SUPPLEMENTARY INFORMATION: The

prospective exclusive license will be

royalty-bearing and will comply with

the terms and conditions of 35 U.S.C.

209 and 37 CFR 404.7. The prospective

exclusive license may be granted unless,

within sixty days from the date of this

published Notice, NIST receives written

evidence and argument which establish

that the grant of the license would not

be consistent with the requirements of

35 U.S.C. 209 and 37 CFR 404.7.

U.S. Patent Number 5,389,523 is a

method of immunoanalysis which

combines immobilized

immunochemistry with the technique of

flow injection analysis, and employs

microscopic spherical structures called

liposomes, or lipid vesicles, as carriers

of detectable reagents.

NIST may enter into a Cooperative

Research and Development Agreement

(‘‘CRADA’’) to perform further research

on the invention for purposes of

commercialization. The CRADA may be

conducted by NIST without any

additional charge to any party that

licenses the patent. NIST may grant the

licensee an option to negotiate for

royalty-free exclusive licenses to any

jointly owned inventions which arise

from the CRADA as well as an option to

negotiate for exclusive royalty-bearing

licenses for NIST employee inventions

which arise from the CRADA.

The availability of the invention for

licensing was published in the Federal

Register, Vol. 57, No. 226 (November

23, 1992). A copy of the patent

application may be obtained from NIST

at the foregoing address.

Dated: December 14, 1995.

Samuel Kramer,

Associate Director.

[FR Doc. 95–30944 Filed 12–19–95; 8:45 am]

BILLING CODE 3510–13–M

DEPARTMENT OF DEFENSE

Proposed Information Collection

Available for Public Comment

ACTION: Notice; correction.

SUMMARY: In FR Doc. 95–29448

concerning a notice of proposed

information collection available for

public comment on Record of Military

Processing—Armed Forces of the United

States; DD Form 1966; OMB Control

Number 0704–0173, appearing on pages

62080 and 62081 in the issue of

Monday, December 4, 1995, change

‘‘Annual Burden Hours:’’ ‘‘423,300

hours’’ to read ‘‘255,000 hours’’ and the

‘‘Average Burden Per Response:’’ ‘‘.83

hours’’ to read ‘‘.5 hours.’’ All other

information remains the same.

FOR FURTHER INFORMATION CONTACT:

Office of the Under Secretary of Defense

for Personnel and Readiness, ATTN:

Reports Clearance Officer, Room 3C980,

4000 Defense Pentagon, Washington, DC

20301–4000, telephone number (703)

614–8989.

Dated: December 15, 1995.

Patricia L. Toppings,

Alternate OSD Federal Register Liaison

Officer, Department of Defense.

[FR Doc. 95–30914 Filed 12–19–95; 8:45 am]

BILLING CODE 5000–04–M

Office of the Secretary

Meeting of the Defense Environmental

Response Task Force

AGENCY: Office of the Deputy Under

Secretary of Defense (Environmental

Security).

ACTION: Notice of business meeting and

hearing.

SUMMARY: Pursuant to Public Law 92–

463, notice is hereby given of a business

meeting and hearing of the Defense

Environmental Response Task Force

(DERTF). The DERTF is charged with

studying and providing findings and

recommendations about environmental

restoration at military installations that

are being closed or realigned. At the

meeting, the DERTF will address issues

related to generic remedies, future land

use, and the environmental aspects of

the base realignment and closure

(BRAC) program. The DERTF also will

be briefed on the cleanup program at the

Orlando Naval Training Center. The

business meeting and hearing will be

open to the public. Public witnesses

who wish to speak before the DERTF

should contract Shah A. Choudhury,

Executive Secretary, and prepare a

written statement that can be

summarized orally before the DERTF at

the time to be fixed for public comment

as stated below. Written statements

must be received by the close of

business, January 5, 1995, at the Office

of the Deputy Under Secretary of

Defense (Environmental Security).

DATES: January 23, 1996, 9:15 a.m.–7

p.m.; January 24, 1996, 9 a.m.–2:45

p.m.; January 25, 1996, 8:15 a.m.–11

a.m.

PUBLIC COMMENT PERIODS ARE: January

23, 1996, 6 p.m.–7 p.m.; January 25,

1996, 8:30 p.m.–9:30 p.m.

ADDRESSES: The Westgate Lakes Hotel,

10,000 Turkey Lake Road, Orlando, FL

32819.

FOR FURTHER INFORMATION CONTACT:

Mr. Shah A. Choudhury, Executive

Secretary, Office of the Deputy Under

Secretary of Defense (Environmental

Security), 3400 Defense Pentagon, Room

3C767, Washington, DC 20301–3400;

telephone (703) 697–7475.

Dated: December 14, 1995.

Patricia L. Toppings,

Alternate OSD Federal Register Liaison

Officer, Department of Defense.

[FR Doc. 95–30852 Filed 12–19–95; 8:45 am]

BILLING CODE 5000–04–M

Office of Secretary

Meeting of the Military Health Advisory

Committee

AGENCY: Department of Defense,

Military Health Care Advisory

Committee.

ACTION: Notice.

SUMMARY: Notice is hereby given of the

forthcoming meeting of the Military